So, FGFBP1 is generally considered an indicator of early stages of pancreatic and colorectal adenocarcinoma [40], and as a biomarker it is very useful in predicting bacillus Calmette–Guérin response in bladder cancer [41]. The gene discussed is FGFBP1; the disease is colorectal adenocarcinoma.